Elisabeth Kogan
Director/Board Member at MEDINCELL S.A.
Net worth: 115 158 $ as of 30/04/2024
Elisabeth Kogan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDINCELL S.A. | Director/Board Member | 15/12/2020 | - |
Clexio Biosciences Ltd.
 Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | - | - |
Career history of Elisabeth Kogan
Statistics
International
| France | 2 |
| Israel | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Clexio Biosciences Ltd.
Clexio Biosciences Ltd. Pharmaceuticals: OtherHealth Technology Clexio Biosciences Ltd. develops novel therapies for patients suffering from neurological and psychiatric conditions. The private company is based in Jerusalem, Israel. The Israeli company was founded by Elena Kagan, Elisabeth Kogan, Menashe Levy. Elisabeth Kogan has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Elisabeth Kogan
- Experience
